Brief by Shorts91 Newsdesk / 04:35pm on 18 Dec 2024,Wednesday Health & Wellness
Russia has developed an mRNA cancer vaccine, launching in early 2025. The vaccine is personalised, using a patient’s tumour to train the immune system to fight cancer. It treats cancer but does not prevent it. The Russian government will provide it free of charge, though it costs 300,000 rubles per dose. Details about its effectiveness and the types of cancer it treats are still unclear. Cancer cases are rising in Russia, with over 635,000 recorded in 2022. The vaccine aims to improve survival rates and is part of ongoing global efforts to develop personalised cancer treatments.
